Addex Therapeutics Ltd
ADXN8.849USD
+0.749+9.24%
Horário de mercado （ET）Cotações atrasadas em 15 min
7.25MValor de mercado
0.96P/L TTM
Mais detalhes de Addex Therapeutics Ltd Empresa
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
Informações da empresa
Código da empresaADXN
Nome da EmpresaAddex Therapeutics Ltd
Data de listagemMay 22, 2007
CEOMr. Tim Dyer
Número de funcionários2
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 22
EndereçoChemin des Mines, 9
CidadePLAN-LES-OUATES
Bolsa de valoresSIX Swiss Exchange
PaísSwitzerland
Código postal1202
Telefone41228841555
Sitehttps://www.addextherapeutics.com/en/
Código da empresaADXN
Data de listagemMay 22, 2007
CEOMr. Tim Dyer
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: dom, 23 de fev
Atualizado em: dom, 23 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
Investidores
Investidores
Proporção
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
Tipos de investidores
Investidores
Proporção
Hedge Fund
1.10%
Investment Advisor/Hedge Fund
0.01%
Other
98.89%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
12
12.04K
1.13%
-165.56K
2025Q1
16
13.11K
1.23%
-176.53K
2024Q4
17
15.10K
1.41%
-160.92K
2024Q3
22
37.43K
5.74%
-146.56K
2024Q2
21
38.45K
5.90%
-143.53K
2024Q1
20
36.44K
5.64%
-145.16K
2023Q4
19
195.87K
20.93%
+138.26K
2023Q3
18
73.39K
96.72%
+38.94K
2023Q2
18
50.23K
7.45%
-253.79K
2023Q1
17
333.00K
49.67%
+248.23K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Citadel Advisors LLC
11.74K
1.1%
-338.00
-2.80%
Mar 31, 2025
GAMMA Investing LLC
1.19K
0.11%
+182.00
+18.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
-1.80K
-94.74%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
-35.00
-32.71%
Mar 31, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Mar 31, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
Baader Bank AG
--
0%
-960.00
-100.00%
Dec 31, 2023
Jane Street Capital, L.L.C.
--
0%
-529.00
-100.00%
Dec 31, 2023
New Enterprise Associates (NEA)
--
0%
-9.00K
-100.00%
Mar 31, 2024
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Data
Tipo
Proporção
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
